Clinical trial of IV folic acid for diagnostic use in patients with ovarian cancer

Trial Profile

Clinical trial of IV folic acid for diagnostic use in patients with ovarian cancer

Suspended
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 23 May 2014

At a glance

  • Drugs Folic acid (Primary)
  • Indications Ovarian cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 23 May 2014 New trial record
    • 19 May 2014 CMA applications from the EMA have been withdrawn for vintafolide and companion imaging components technetium-Tc99m etarfolatide and intravenous folic acid based on further review of interim data from the PROCEED trial, according to Merck and Endocyte.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top